Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2021-09-24 21:16:17 UTC |
---|
Update Date | 2021-09-24 21:16:18 UTC |
---|
HMDB ID | HMDB0304897 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Revefenacin |
---|
Description | Revefenacin, also known as yupelri, belongs to the class of organic compounds known as n-benzylpiperidines. These are heterocyclic Compounds containing a piperidine ring conjugated to a benzyl group through one nitrogen ring atom. Based on a literature review very few articles have been published on Revefenacin. |
---|
Structure | CN(CCN1CCC(CC1)OC(=O)NC1=CC=CC=C1C1=CC=CC=C1)C(=O)C1=CC=C(CN2CCC(CC2)C(N)=O)C=C1 InChI=1S/C35H43N5O4/c1-38(34(42)29-13-11-26(12-14-29)25-40-19-15-28(16-20-40)33(36)41)23-24-39-21-17-30(18-22-39)44-35(43)37-32-10-6-5-9-31(32)27-7-3-2-4-8-27/h2-14,28,30H,15-25H2,1H3,(H2,36,41)(H,37,43) |
---|
Synonyms | Value | Source |
---|
Yupelri | MeSH | Biphenyl-2-ylcarbamic acid 1-(2-((4-(4-carbamoylpiperidin-1-ylmethyl)benzoyl)methylamino)ethyl)piperidin-4-yl ester | MeSH | 1-({4-[(2-{4-[({[1,1'-biphenyl]-2-yl}-C-hydroxycarbonimidoyl)oxy]piperidin-1-yl}ethyl)(methyl)carbamoyl]phenyl}methyl)piperidine-4-carboximidate | Generator |
|
---|
Chemical Formula | C35H43N5O4 |
---|
Average Molecular Weight | 597.76 |
---|
Monoisotopic Molecular Weight | 597.331504885 |
---|
IUPAC Name | 1-[2-(1-{4-[(4-carbamoylpiperidin-1-yl)methyl]phenyl}-N-methylformamido)ethyl]piperidin-4-yl N-{[1,1'-biphenyl]-2-yl}carbamate |
---|
Traditional Name | 1-[2-(1-{4-[(4-carbamoylpiperidin-1-yl)methyl]phenyl}-N-methylformamido)ethyl]piperidin-4-yl N-{[1,1'-biphenyl]-2-yl}carbamate |
---|
CAS Registry Number | Not Available |
---|
SMILES | CN(CCN1CCC(CC1)OC(=O)NC1=CC=CC=C1C1=CC=CC=C1)C(=O)C1=CC=C(CN2CCC(CC2)C(N)=O)C=C1 |
---|
InChI Identifier | InChI=1S/C35H43N5O4/c1-38(34(42)29-13-11-26(12-14-29)25-40-19-15-28(16-20-40)33(36)41)23-24-39-21-17-30(18-22-39)44-35(43)37-32-10-6-5-9-31(32)27-7-3-2-4-8-27/h2-14,28,30H,15-25H2,1H3,(H2,36,41)(H,37,43) |
---|
InChI Key | FYDWDCIFZSGNBU-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as n-benzylpiperidines. These are heterocyclic Compounds containing a piperidine ring conjugated to a benzyl group through one nitrogen ring atom. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Piperidines |
---|
Sub Class | Benzylpiperidines |
---|
Direct Parent | N-benzylpiperidines |
---|
Alternative Parents | |
---|
Substituents | - N-benzylpiperidine
- Biphenyl
- Phenylcarbamic acid ester
- Benzamide
- Benzoic acid or derivatives
- Piperidinecarboxamide
- Benzoyl
- Benzylamine
- Phenylmethylamine
- Aralkylamine
- Benzenoid
- Monocyclic benzene moiety
- Tertiary carboxylic acid amide
- Carbamic acid ester
- Tertiary aliphatic amine
- Tertiary amine
- Primary carboxylic acid amide
- Carboxamide group
- Amino acid or derivatives
- Azacycle
- Carboxylic acid derivative
- Organooxygen compound
- Organic oxide
- Carbonyl group
- Amine
- Organic oxygen compound
- Hydrocarbon derivative
- Organic nitrogen compound
- Organonitrogen compound
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | Not Available |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Revefenacin,1TMS,isomer #1 | CN(CCN1CCC(OC(=O)NC2=CC=CC=C2C2=CC=CC=C2)CC1)C(=O)C1=CC=C(CN2CCC(C(=O)N[Si](C)(C)C)CC2)C=C1 | 4994.9 | Semi standard non polar | 33892256 | Revefenacin,1TMS,isomer #1 | CN(CCN1CCC(OC(=O)NC2=CC=CC=C2C2=CC=CC=C2)CC1)C(=O)C1=CC=C(CN2CCC(C(=O)N[Si](C)(C)C)CC2)C=C1 | 3864.8 | Standard non polar | 33892256 | Revefenacin,1TMS,isomer #1 | CN(CCN1CCC(OC(=O)NC2=CC=CC=C2C2=CC=CC=C2)CC1)C(=O)C1=CC=C(CN2CCC(C(=O)N[Si](C)(C)C)CC2)C=C1 | 6591.2 | Standard polar | 33892256 | Revefenacin,1TMS,isomer #2 | CN(CCN1CCC(OC(=O)N(C2=CC=CC=C2C2=CC=CC=C2)[Si](C)(C)C)CC1)C(=O)C1=CC=C(CN2CCC(C(N)=O)CC2)C=C1 | 4907.4 | Semi standard non polar | 33892256 | Revefenacin,1TMS,isomer #2 | CN(CCN1CCC(OC(=O)N(C2=CC=CC=C2C2=CC=CC=C2)[Si](C)(C)C)CC1)C(=O)C1=CC=C(CN2CCC(C(N)=O)CC2)C=C1 | 3619.1 | Standard non polar | 33892256 | Revefenacin,1TMS,isomer #2 | CN(CCN1CCC(OC(=O)N(C2=CC=CC=C2C2=CC=CC=C2)[Si](C)(C)C)CC1)C(=O)C1=CC=C(CN2CCC(C(N)=O)CC2)C=C1 | 6961.3 | Standard polar | 33892256 | Revefenacin,2TMS,isomer #1 | CN(CCN1CCC(OC(=O)N(C2=CC=CC=C2C2=CC=CC=C2)[Si](C)(C)C)CC1)C(=O)C1=CC=C(CN2CCC(C(=O)N[Si](C)(C)C)CC2)C=C1 | 4789.1 | Semi standard non polar | 33892256 | Revefenacin,2TMS,isomer #1 | CN(CCN1CCC(OC(=O)N(C2=CC=CC=C2C2=CC=CC=C2)[Si](C)(C)C)CC1)C(=O)C1=CC=C(CN2CCC(C(=O)N[Si](C)(C)C)CC2)C=C1 | 3798.1 | Standard non polar | 33892256 | Revefenacin,2TMS,isomer #1 | CN(CCN1CCC(OC(=O)N(C2=CC=CC=C2C2=CC=CC=C2)[Si](C)(C)C)CC1)C(=O)C1=CC=C(CN2CCC(C(=O)N[Si](C)(C)C)CC2)C=C1 | 6191.1 | Standard polar | 33892256 | Revefenacin,2TMS,isomer #2 | CN(CCN1CCC(OC(=O)NC2=CC=CC=C2C2=CC=CC=C2)CC1)C(=O)C1=CC=C(CN2CCC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)CC2)C=C1 | 5017.5 | Semi standard non polar | 33892256 | Revefenacin,2TMS,isomer #2 | CN(CCN1CCC(OC(=O)NC2=CC=CC=C2C2=CC=CC=C2)CC1)C(=O)C1=CC=C(CN2CCC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)CC2)C=C1 | 4024.1 | Standard non polar | 33892256 | Revefenacin,2TMS,isomer #2 | CN(CCN1CCC(OC(=O)NC2=CC=CC=C2C2=CC=CC=C2)CC1)C(=O)C1=CC=C(CN2CCC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)CC2)C=C1 | 6364.9 | Standard polar | 33892256 | Revefenacin,3TMS,isomer #1 | CN(CCN1CCC(OC(=O)N(C2=CC=CC=C2C2=CC=CC=C2)[Si](C)(C)C)CC1)C(=O)C1=CC=C(CN2CCC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)CC2)C=C1 | 4863.7 | Semi standard non polar | 33892256 | Revefenacin,3TMS,isomer #1 | CN(CCN1CCC(OC(=O)N(C2=CC=CC=C2C2=CC=CC=C2)[Si](C)(C)C)CC1)C(=O)C1=CC=C(CN2CCC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)CC2)C=C1 | 3989.6 | Standard non polar | 33892256 | Revefenacin,3TMS,isomer #1 | CN(CCN1CCC(OC(=O)N(C2=CC=CC=C2C2=CC=CC=C2)[Si](C)(C)C)CC1)C(=O)C1=CC=C(CN2CCC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)CC2)C=C1 | 5913.0 | Standard polar | 33892256 | Revefenacin,1TBDMS,isomer #1 | CN(CCN1CCC(OC(=O)NC2=CC=CC=C2C2=CC=CC=C2)CC1)C(=O)C1=CC=C(CN2CCC(C(=O)N[Si](C)(C)C(C)(C)C)CC2)C=C1 | 5156.9 | Semi standard non polar | 33892256 | Revefenacin,1TBDMS,isomer #1 | CN(CCN1CCC(OC(=O)NC2=CC=CC=C2C2=CC=CC=C2)CC1)C(=O)C1=CC=C(CN2CCC(C(=O)N[Si](C)(C)C(C)(C)C)CC2)C=C1 | 4135.9 | Standard non polar | 33892256 | Revefenacin,1TBDMS,isomer #1 | CN(CCN1CCC(OC(=O)NC2=CC=CC=C2C2=CC=CC=C2)CC1)C(=O)C1=CC=C(CN2CCC(C(=O)N[Si](C)(C)C(C)(C)C)CC2)C=C1 | 6600.5 | Standard polar | 33892256 | Revefenacin,1TBDMS,isomer #2 | CN(CCN1CCC(OC(=O)N(C2=CC=CC=C2C2=CC=CC=C2)[Si](C)(C)C(C)(C)C)CC1)C(=O)C1=CC=C(CN2CCC(C(N)=O)CC2)C=C1 | 5119.5 | Semi standard non polar | 33892256 | Revefenacin,1TBDMS,isomer #2 | CN(CCN1CCC(OC(=O)N(C2=CC=CC=C2C2=CC=CC=C2)[Si](C)(C)C(C)(C)C)CC1)C(=O)C1=CC=C(CN2CCC(C(N)=O)CC2)C=C1 | 3912.0 | Standard non polar | 33892256 | Revefenacin,1TBDMS,isomer #2 | CN(CCN1CCC(OC(=O)N(C2=CC=CC=C2C2=CC=CC=C2)[Si](C)(C)C(C)(C)C)CC1)C(=O)C1=CC=C(CN2CCC(C(N)=O)CC2)C=C1 | 6939.6 | Standard polar | 33892256 | Revefenacin,2TBDMS,isomer #1 | CN(CCN1CCC(OC(=O)N(C2=CC=CC=C2C2=CC=CC=C2)[Si](C)(C)C(C)(C)C)CC1)C(=O)C1=CC=C(CN2CCC(C(=O)N[Si](C)(C)C(C)(C)C)CC2)C=C1 | 5151.4 | Semi standard non polar | 33892256 | Revefenacin,2TBDMS,isomer #1 | CN(CCN1CCC(OC(=O)N(C2=CC=CC=C2C2=CC=CC=C2)[Si](C)(C)C(C)(C)C)CC1)C(=O)C1=CC=C(CN2CCC(C(=O)N[Si](C)(C)C(C)(C)C)CC2)C=C1 | 4367.4 | Standard non polar | 33892256 | Revefenacin,2TBDMS,isomer #1 | CN(CCN1CCC(OC(=O)N(C2=CC=CC=C2C2=CC=CC=C2)[Si](C)(C)C(C)(C)C)CC1)C(=O)C1=CC=C(CN2CCC(C(=O)N[Si](C)(C)C(C)(C)C)CC2)C=C1 | 6186.7 | Standard polar | 33892256 | Revefenacin,2TBDMS,isomer #2 | CN(CCN1CCC(OC(=O)NC2=CC=CC=C2C2=CC=CC=C2)CC1)C(=O)C1=CC=C(CN2CCC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)CC2)C=C1 | 5331.5 | Semi standard non polar | 33892256 | Revefenacin,2TBDMS,isomer #2 | CN(CCN1CCC(OC(=O)NC2=CC=CC=C2C2=CC=CC=C2)CC1)C(=O)C1=CC=C(CN2CCC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)CC2)C=C1 | 4579.9 | Standard non polar | 33892256 | Revefenacin,2TBDMS,isomer #2 | CN(CCN1CCC(OC(=O)NC2=CC=CC=C2C2=CC=CC=C2)CC1)C(=O)C1=CC=C(CN2CCC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)CC2)C=C1 | 6291.7 | Standard polar | 33892256 |
|
---|
| MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Revefenacin 10V, Positive-QTOF | splash10-0f6t-0645790000-641f1a52fd27fb341be6 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Revefenacin 20V, Positive-QTOF | splash10-014i-0943210000-9d5dc2932532f3ba20e3 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Revefenacin 40V, Positive-QTOF | splash10-014j-0940000000-349d9975fec5d95a05ad | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Revefenacin 10V, Negative-QTOF | splash10-0007-0910330000-43671787dda8481e523b | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Revefenacin 20V, Negative-QTOF | splash10-00kf-0911110000-8bc4af1cb36d004a80a6 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Revefenacin 40V, Negative-QTOF | splash10-00kf-4910000000-0f2db02386b403b45625 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Revefenacin 10V, Positive-QTOF | splash10-0002-0001090000-1072b90b380da46d9c4d | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Revefenacin 20V, Positive-QTOF | splash10-0002-0234290000-bef4d8ec5b012c3f1219 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Revefenacin 40V, Positive-QTOF | splash10-0002-5945020000-07843a1dc4454660669c | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Revefenacin 10V, Negative-QTOF | splash10-0002-0041190000-7d0207050c49ebd7f3c1 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Revefenacin 20V, Negative-QTOF | splash10-0hfw-1653290000-2df29617f8d75130cd81 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Revefenacin 40V, Negative-QTOF | splash10-0006-5920040000-d6323f2b7aea2e741eaf | 2021-10-11 | Wishart Lab | View Spectrum |
|
---|